Chargement en cours...
Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
CONTEXT: Lipodystrophies are extreme forms of metabolic syndrome. Metreleptin was approved in the United States for generalized lipodystrophy (GLD) but not partial lipodystrophy (PLD). OBJECTIVE: The objective of the study was to test metreleptin's efficacy in PLD vs GLD and find predictors for...
Enregistré dans:
| Publié dans: | J Clin Endocrinol Metab |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Endocrine Society
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422900/ https://ncbi.nlm.nih.gov/pubmed/25734254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-4491 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|